BioNTech SE Reports Earnings Results for the First Quarter Ended March 31, 2022
May 09, 2022 at 06:01 am EDT
BioNTech SE reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was EUR 6,362.2 million compared to EUR 2,027.5 million a year ago. Revenue was EUR 6,374.6 million compared to EUR 2,048.4 million a year ago. Net income was EUR 3,698.8 million compared to EUR 1,128.1 million a year ago. Basic earnings per share from continuing operations was EUR 15.13 compared to EUR 4.64 a year ago. Diluted earnings per share from continuing operations was EUR 14.24 compared to EUR 4.39 a year ago.